Vandana Singh

Contributing Author

Recent Articles by Vandana Singh

Mar-11	Why Is AeroVironment Stock Tanking Wednesday? AVAV -6.25% ARKQ ARKX XAR Benzinga
Mar-10	BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz BBIO +13.22% PFE ALNY BMRN Benzinga
Mar-10	Evotec Restructuring Aims To Improve Profitability After Transition Year EVO -11.88% EVO -6.37% Benzinga
Mar-10	FDA Expands Use Of Generic Drug To Treat Autism-Linked Genetic Disorder KVUE JNJ GSK Benzinga
Mar-10	Why Is Centene Stock Falling On Tuesday? CNC -15.97% Benzinga
Mar-10	Medtronic's $550 Million Scientia Vascular Deal Aims To Boost Neurovascular Portfolio MDT ESLV DIVP SAMM Benzinga
Mar-10	Teladoc Health Stock Pops - Here's Why TDOC +5.09% Benzinga
Mar-10	MiNK Therapeutics Pediatric Cancer Breakthrough Sparks Stock Rally INKT +29.28% Benzinga
Mar-10	Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps VRTX +8.31% IBB QFRD BBH Benzinga
Mar-10	BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture BNTX -17.88% MRNA PFE BMY Benzinga
Mar-10	EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue NXGL -15.77% CELU +11.20% Benzinga
Mar-10	Why Is Telix Pharmaceuticals Stock Gaining Tuesday? TLX +5.47% Benzinga
Mar-09	What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday? QURE +26.07% RGNX +20.00% SLDB +18.81% CAPR +9.78% MRNA +6.13% +2 More Benzinga
Mar-09	Why Is Olema Pharmaceuticals Stock Dropping On Monday? OLMA -25.75% NVS PFE Benzinga
Mar-09	What's Going On With Biohaven Stock On Monday? XENE +49.64% BHVN PINK Benzinga
Mar-09	ImmunityBio Announces FDA Resubmission For Expanded Use Of Lead Drug IBRX BBP Benzinga
Mar-09	Mid-Cap NovaBridge Biosciences Stock Jumps Fueled By Positive Study Data In Eye Disease NBP Benzinga
Mar-09	AbbVie's Early Obesity Drug Data Shows Up To 10% Weight Loss ABBV XLV IYH Benzinga
Mar-09	Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures XENE +49.64% IBRN +5.35% RAPP PRAX Benzinga
Mar-09	Dianthus Therapeutics Stock Rallies-Rare Disease Study Success Fuels Optimism DNTH +21.52% SNY Benzinga
Mar-09	Why Is Relmada Therapeutics Stock Soaring Monday? RLMD +61.12% Benzinga
Mar-09	Roche's Breast Cancer Drug Falls Short In Phase 3 Study NVO LLY Benzinga
Mar-09	Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars HIMS +40.79% NVO SLYG VIOO SPSM Benzinga
Mar-09	Why Is uniQure Stock Skyrocketing Monday? QURE +26.07% MRNA +6.13% SRPT +5.57% Benzinga
Mar-06	OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty OPRX -10.49% Benzinga
Mar-06	What's Going On With Iovance Biotherapeutics Stock On Friday? IOVA +12.01% IOVA +5.46% Benzinga
Mar-06	Tevogen Bio Explores Buyout To Boost Generics Platform TVGN +6.02% TVGN -5.74% Benzinga
Mar-06	What's Going On With Firefly Neuroscience Stock On Friday? AIFF +30.28% AIFF -9.73% NVDA Benzinga
Mar-06	Why Are BioXcel Therapeutics Shares Down Friday? BTAI -8.07% Benzinga
Mar-06	What's Going On With Palladyne AI Stock Friday? PDYN -14.36% Benzinga
Mar-06	FDA Clears Johnson & Johnson's Multiple Myeloma Combo Drug After Strong Survival Results JNJ Benzinga
Mar-06	Why Is Omada Health Stock Soaring Friday? OMDA Benzinga
Mar-06	China Clears Weight-Loss Shot As Pfizer Enters Crowded Market PFE NVO Benzinga
Mar-06	Roche's Obesity Drug Shows Promise But Trails GLP-1 Giants Novo Nordisk And Eli Lilly NVO LLY Benzinga
Mar-05	Tenaya Therapeutics Stock Jumps After New Alnylam Deal TNYA +40.92% ALNY Benzinga
Mar-05	Veeva Systems Analyst Says AI Push Keeps Stock Attractive VEEV Benzinga
Mar-05	FDA Defends Call For Placebo Study In uniQure Huntington's Gene Therapy Trial QURE +33.99% QURE +17.81% Benzinga
Mar-05	Palladyne AI Forecasts Fourfold Revenue Growth In 2026 PDYN +34.05% PDYN -14.36% Benzinga
Mar-05	Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints HELP -33.88% ATAI VTGN Benzinga
Mar-05	Medicus Pharma Stock Swings After Skin Cancer Treatment Results MDCX -50.88% Benzinga
Mar-05	BioXcel Therapeutics Stock Rallies Opioid Study Success BTAI Benzinga
Mar-05	What's Going On With Webull Stock Thursday? BULL -5.60% HOOD SCHW Benzinga
Mar-05	Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor XNCR -12.40% AZN Benzinga
Mar-05	FDA Places Partial Hold On PepGen's Myotonic Dystrophy Drug Trial PEPG -18.57% Benzinga
Mar-04	What's Going On With Anavex Life Sciences Stock On Wednesday? AVXL +6.61% Benzinga
Mar-04	KALA BIO Eyes Pharma R&D Spend With Secure AI Licensing Model KALA -20.36% KALA Benzinga
Mar-04	What's Going With SELLAS Life Sciences Stock On Wednesday? SLS Benzinga
Mar-04	Firefly Neuroscience Skyrockets - Brain Scan Breakthrough Fuels Rally AIFF +126.28% AIFF -8.39% Benzinga
Mar-04	Micro-Cap Can-Fite BioPharma Shares Surge On Successful Pancreatic Cancer Drug Study CANF +20.40% Benzinga
Mar-04	What's Going On With uniQure Stock Wednesday? QURE Benzinga
Mar-04	What's Going On With Aardvark Therapeutics Stock On Wednesday? AARD +15.10% Benzinga
Mar-04	Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars MRNA +15.99% ROIV +6.00% BNTX ABUS Benzinga
Mar-04	Klotho Neurosciences Expands Into Mining With Greenland Mines Deal Benzinga
Mar-04	Klotho Neurosciences Expands Into Mining With Greenland Mines Deal Benzinga
Mar-04	EXCLUSIVE: Hoth Therapeutics Integrates OpenAI API To Support Drug Development For Aggressive Cancers NVO +5.02% HOTH Benzinga
Mar-03	AI-Powered Tempus Inks New Multi-Year Merck Deal TEM MRK Benzinga
Mar-03	Core Scientific's Bitcoin Mining Revenue Slides, But CoreWeave Deal Ahead of Schedule CRWV +7.75% CORZ -7.22% CRWV -5.47% Benzinga
Mar-03	Theravance Biopharma Plummets As Phase 3 Study Falls Short TBPH -26.33% Benzinga
Mar-03	Nvidia's Genomic Analysis Suite To Help Speed Up Residual Cancer Detection COHR -6.06% NVDA Benzinga
Mar-03	What's Going On With Penny Stock OneMedNet On Tuesday? ONMD -12.54% ONMD PLTR Benzinga
Mar-03	Why Is Eye-Disease-Focused Harrow Stock Falling Today? HROW -27.96% Benzinga
Mar-03	EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million ADIL -7.29% Benzinga
Mar-03	Credo Technology Strong Earnings FailS To Stem Stock Slide CRDO -14.81% Benzinga
Mar-03	Tonix Pharmaceuticals Stock Dips After Nasdaq Uplisting TNXP Benzinga
Mar-03	Surgery Partners Stock Hits 52-Week Low - Here's Why SGRY -12.34% Benzinga
Mar-03	Coherent Stock Pulls Back After 15% Surge On Multibillion Nvidia AI Deal COHR -6.06% NVDA Benzinga
Mar-02	Elevance Health Stock Sinks After CMS Freezes Medicare Advantage Enrollment ELV -8.10% Benzinga
Mar-02	AbbVie Says 55% Of Crohn's Patients Reached Remission With Skyrizi, Bolsters Competitive Positioning Against Johnson & Johnson ABBV JNJ Benzinga
Mar-02	Tilray Brands Acquires BrewDog Assets - A $200 Million Revenue Boost On The Horizon TLRY Benzinga
Mar-02	Tilray Brands Acquires BrewDog Assets - A $200 Million Revenue Boost On The Horizon TLRY Benzinga
Mar-02	Weight Loss Data From Obese Mice Looks Promising For Alaunos Therapeutics, But Shares Drop TCRT Benzinga
Mar-02	Tiny Biotech Rallybio Stock Surges As $500 Million-Backed Merger Fuels Investor Optimism RLYB +45.49% Benzinga
Mar-02	United Therapeutics' Trial Shows 55% Drop in Lung Disease Worsening UTHR Benzinga
Mar-02	Intellia Therapeutics Stock Gains - FDA Lifts Clinical Hold On Pivotal Trial NTLA +12.05% Benzinga
Mar-02	Rhythm Pharmaceuticals Discloses 18.8% BMI Drop In Rare Obesity Patients RYTM Benzinga
Mar-02	uniQure Stock Plunges 40% After FDA Shocker QURE -32.82% Benzinga
Mar-02	Ascendis Wins FDA Approval For Rare Disease Therapy ASND Benzinga
Mar-02	Why Is Aardvark Therapeutics Stock Sinking Monday? AARD -56.20% Benzinga
Mar-02	BioMarin Strengthens PKU Portfolio With FDA Approval For Younger Patients BMRN FOLD Benzinga
Feb-27	What's Going On With Novavax Stock On Friday? NVAX -9.38% SNY Benzinga
Feb-27	Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review ENSC +57.77% Benzinga
Feb-27	Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter DNA -30.48% Benzinga
Feb-27	ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% ANIP Benzinga
Feb-27	Generic Drugs Focused Amneal Pharmaceuticals Revenue Crosses $800 Million AMRX Benzinga
Feb-27	Neurogene Stock Soars On FDA Breakthrough Tag For Rett Gene Therapy NGNE +19.36% Benzinga
Feb-27	Cancer Test Maker Caris Life Sciences Unveils Breakthrough In Early Cancer Detection, Profit Surprise CAI Benzinga
Feb-27	Why Is Duolingo Stock Sinking Friday? DUOL -14.01% Benzinga
Feb-26	Boston Scientific Halts Use Of Select Stent Delivery Devices After Patient Deaths BSX Benzinga
Feb-26	Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients BMY Benzinga
Feb-26	COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb NVAX +17.42% NVAX -9.38% Benzinga
Feb-26	Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2 NVO LLY Benzinga
Feb-26	What's Driving Teladoc Health's Rally? TDOC +15.05% Benzinga
Feb-26	AtaiBeckley Touts Social Anxiety Breakthrough With Phase 2 Trial Data ATAI -14.06% Benzinga
Feb-26	Argenx Touts Positive Phase 3 Eye Disease Study Results ARGX -5.56% Benzinga
Feb-26	ImmunityBio Investors Rally Behind Cancer Trial Milestone IBRX Benzinga
Feb-26	IonQ Stock Gains, Europe's Quantum Leap Sparks Rally IONQ +21.70% Benzinga
Feb-26	PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why PRCT -15.12% Benzinga
Feb-26	Sarepta CEO To Jump Ship After 'Tumultuous' Year SRPT -8.01% DYN Benzinga
Feb-25	Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment PFE Benzinga
Feb-25	ImmunityBio Supersedes Expectations With Fivefold Revenue Increase IBRX -17.40% Benzinga

Vandana Singh

Recent Articles by Vandana Singh

Upgrade your FINVIZ experience